Table 3. Prognostic significance from Cox model using backward selection.
| Variable | Parameter estimate | P-value | Hazard Ratio | 95% CI for HR |
|---|---|---|---|---|
| Stage (I vs II/III) | 0.55 | 0.035 | 1.73 | 1.04–2.87 |
| KRAS mutation | −0.95 | 0.016 | 0.39 | 0.18–0.84 |
| EGFR C | 0.9 | 0.015 | 2.45 | 1.19–5.02 |
| E-cadherin.C | −0.96 | 0.0069 | 0.38 | 0.19–0.77 |
| pSTAT3.N | −1.18 | 0.0006 | 0.31 | 0.16–0.60 |
| pCMET.1003.C | 0.78 | 0.0049 | 2.16 | 1.27–3.73 |
Abbreviations: EGFR=epidermal growth factor receptor; CI=confidence interval; HR=Hazard ratio.